Side-by-side comparison of AI visibility scores, market position, and capabilities
New York City largest US bank (NYSE: JPM) $177B FY2024 net revenue, $58.5B net income (record); IB fees +49%, First Republic acquisition 2023, #1 consumer deposits and IB competing with Goldman and Bank of America.
JPMorgan Chase & Co. is a New York City-based global financial services company — publicly traded on the New York Stock Exchange (NYSE: JPM) as a Dow Jones Industrial Average and S&P 500 Financials component — providing investment banking, financial services for consumers and small businesses (Chase banking), commercial banking, financial transaction processing, and asset and wealth management through approximately 316,000 employees in 60+ countries. JPMorgan Chase is the largest US bank by assets ($3.9 trillion) and market capitalization ($600B+), formed through the 2000 merger of J.P. Morgan & Co. with Chase Manhattan Bank, subsequent acquisition of Bank One in 2004 (bringing Jamie Dimon as CEO), acquisition of Bear Stearns in March 2008 (emergency government-assisted rescue during the financial crisis), acquisition of Washington Mutual's banking assets from FDIC receivership in September 2008, and the May 2023 acquisition of First Republic Bank from FDIC receivership (adding $92B in deposits, $173B in loans, and 80 wealth management offices following First Republic's collapse from SVB-contagion bank run). In fiscal year 2024, JPMorgan Chase reported total net revenues of $177 billion and net income of $58.5 billion — the highest annual profit ever reported by a US bank — driven by investment banking fee recovery ($8.7B IB fees, +49% year-over-year as M&A and IPO markets recovered), net interest income strength from high-rate environment, and consumer bank deposit and loan growth. CEO Jamie Dimon has led JPMorgan Chase for 20 years, making it the only major US bank to avoid TARP (Troubled Asset Relief Program) losses during the 2008 financial crisis and growing it into the dominant US financial services franchise with #1 market share in global investment banking, US credit cards (Chase Freedom, Sapphire, Ink business cards), US consumer deposits, US wealth management, and US commercial real estate lending.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.